Therapeutic efficacy of Nexavar on liver cancer and its relation to the expression of Ki-67 and CD34 / 南方医科大学学报
Journal of Southern Medical University
;
(12): 1930-1934, 2010.
Article
in Chinese
| WPRIM
| ID: wpr-330801
ABSTRACT
<p><b>OBJECTIVE</b>To study the therapeutic effects of Nexavar on liver cancer and its relation to the expressions of Ki-67 and CD34.</p><p><b>METHODS</b>Twenty-eight patients with liver cancer were treated with Nexavar. The therapeutic efficacy of Nexavar on liver cancer was observed. Liver cancer tissues were examined for the expressions of Ki-67 and CD34 by immunohistochemistry. Microvessel density (MVD) was calculated according to the expression of CD34.</p><p><b>RESULTS</b>Of 28 patients, none achieved a complete response (CR), 12 had a partial response (PR), 7 had stable disease (SD), and 9 progressive disease (PD). The efficacy of Nexavar was associated significantly with Ki-67 expression. The mean MVD count was 346.03-/+146.98 in PR patients, and 89.14-/+45.66 in PD patients. There was a significant difference in MVD between PR and PD patients.</p><p><b>CONCLUSION</b>There is a better efficacy of Nexavar in treatment of liver cancer in the patients who had Ki-67-positive expression and high MVD count.</p>
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Phenylurea Compounds
/
Niacinamide
/
Antigens, CD34
/
Ki-67 Antigen
/
Therapeutic Uses
/
Drug Therapy
/
Liver Neoplasms
/
Metabolism
/
Antineoplastic Agents
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
Language:
Chinese
Journal:
Journal of Southern Medical University
Year:
2010
Type:
Article
Similar
MEDLINE
...
LILACS
LIS